International Journal on Magnetic Particle Imaging IJMPI
Vol. 12 No. 1 Suppl 1 (2026): Int J Mag Part Imag

Short Abstracts, ID 938

Coagulation Induced MPS-Signal Changes in Human Blood Samples

Main Article Content

Maria-Josephina Buhné (Institute of Radiology and Nuclear Medicine, University Hospital Luebeck Schleswig Holstein), Justin Ackers (Fraunhofer IMTE, Fraunhofer Research Institution for Individualized and Cell-Based Medical Engineering, Luebeck, Germany), Mandy Ahlborg  (Fraunhofer IMTE, Fraunhofer Research Institution for Individualized and Cell-Based Medical Engineering, Luebeck, Germany), Matthias Graeser (1) Fraunhofer IMTE, Fraunhofer Research Institution for Individualized and Cell-Based Medical Engineering, Luebeck, Germany; 2) Faculty of Computer Science and Electrical Engineering, University Rostock, Rostock, Germany), Throsten Buzug  (1) Fraunhofer IMTE, Fraunhofer Research Institution for Individualized and Cell-Based Medical Engineering, Luebeck, Germany; 2)Institute of Medical Engineering, University of Luebeck, Luebeck, Germany), Kerstin Lüdtke-Buzug  (Institute of Medical Engineering, University of Luebeck, Luebeck, Germany), Tobias Knopp (1) Fraunhofer IMTE, Fraunhofer Research Institution for Individualized and Cell-Based Medical Engineering, Luebeck, Germany, 2) Section for Biomedical Imaging, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, 3)Institute for Biomedical Imaging, Hamburg University of Technology, Hamburg, Germany), Jonas Stroeder  (Institute of Radiology and Nuclear Medicine, University Hospital Schleswig-Holstein, Luebeck, Germany), Jörg Barkhausen (Institute of Radiology and Nuclear Medicine, University Hospital Schleswig-Holstein, Luebeck, Germany), Roman Kloeckner (Institute of Interventional Radiology, University Hospital Schleswig-Holstein, Luebeck, Germany), Alex Frydrychowicz (Institute of Radiology and Nuclear Medicine, University Hospital Schleswig-Holstein, Luebeck, Germany), Franz Wegner (Institute of Interventional Radiology, University Hospital Schleswig-Holstein, Luebeck, Germany), Eric Aderhold (Fraunhofer IMTE, Fraunhofer Research Institution for Individualized and Cell-Based Medical Engineering, Luebeck, Germany)

Abstract

With the clinical approval of the MRI contrast agent Resotran and the development of first human-scale Magnetic Particle Imaging (MPI) scanners, clinical applications of MPI are within reach. Magnetic Particle Spectroscopy (MPS), the non-imaging counterpart of MPI, allows for highly sensitive analysis by utilizing the signal responses of magnetic nanoparticles. The use of MPS as point-of-care (PoC) devices and -applications is very advantageous. In this study, we evaluate the potential of MPS to monitor blood coagulation in real time.


 

Article Details

References

[1] B. Gleich and J. Weizenecker, “Tomographic imaging using the nonlinear response of magnetic particles,” Nature, vol. 435, no. 7046, pp. 1214–1217, Jun. 2005, doi: 10.1038/nature03808.
[2] E. U. Saritas et al., “Magnetic Particle Imaging (MPI) for NMR and MRI researchers,” J. Magn. Reson., vol. 229, pp. 116–126, Apr. 2013, doi: 10.1016/j.jmr.2012.11.029.
[3] P. Vogel et al., “Critical Offset Magnetic Particle SpectroScopy for rapid and highly sensitive medical point-of-care diagnostics,” Nat. Commun., vol. 13, no. 1, p. 7230, Nov. 2022, doi: 10.1038/s41467-022-34941-y.

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 > >>